A pilot study of effects of exenatide on body weight in non-diabetic, obese patients
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Amylin Pharmaceuticals
- 23 Mar 2010 Results in patients with or without pre-diabetes were reported in Diabetes Care.
- 11 Jun 2009 Results have been published as an abstract in the proceedings of the 91st Annual Meeting of the Endocrine Society.
- 04 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.